Clinical trial
A Phase 2A Study of Soy Isoflavones in the Treatment of Major Depression
NCT00042380 is registered in ClinicalTrials.gov with National Institute of Mental Health (NIMH) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2A Study of Soy Isoflavones in the Treatment of Major Depression
- Lead sponsor
- National Institute of Mental Health (NIMH)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2002
- Completion date
- April 30, 2005
- Enrollment
- 120
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression